- Home
- ABEO vs HNST Comparison
ABEO vs HNST Comparison
Compare ABEO & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | HNST |
|---|---|---|
| Founded | 1974 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 375.4M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABEO | HNST |
|---|---|---|
| Price | $5.80 | $3.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $20.00 | $3.05 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $371,317,000.00 |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | $5.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $2.07 |
| 52 Week High | $7.54 | $5.28 |
Technical Indicators
Market Signals| Indicator | ABEO | HNST |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 54.54 |
| Support Level | $5.20 | $3.26 |
| Resistance Level | $6.07 | $4.09 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 75.40 | 61.60 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About HNST The Honest Company Inc.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.